Agilent Inks Sequence-Enrichment Deal with Life Tech; Says Varian Acquisition is on Track
September 21, 2009
Agilent Inks Sequence-Enrichment Deal with Life Tech; Says Varian Acquisition is on Track
An Agilent official who disclosed the agreement at the UBS Global Life Sciences Conference also noted that the company's proposed $1.5 billion acquisition of Varian is on track to be completed by the end of the year.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Agilent Snags Life Technologies as Latest Co-Marketing Partner for SureSelect Target-Enrichment System
September 22, 2009 / BioArray News - Exome Sequencing Points to De Novo, Dominant Mutations as the Cause of a Rare, Lethal Disorder
June 1, 2010 / In Sequence - Q&A: ARUP Labs' Karl Voelkerding Discusses Bringing Next-Gen Sequencing to the Clinical Setting
March 30, 2010 / In Sequence - Array Firms Debut New Products to Cash in on 'Lucrative' Sequence-Capture Market
July 14, 2009 / BioArray News - Dutch Team IDs New Intellectual Disability Genes in Diagnostic Exome Sequencing Pilot
October 4, 2012 / GenomeWeb Daily News